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Background: Extended systemic lymphadenectomy (D2) is standard procedure for surgical treatment of advanced
gastric cancer (AGC) although less extensive lymphadenectomy (D1) can be applied to early gastric cancer.
Complete D2 lymphadenectomy is the mandatory procedure for studies that evaluate surgical treatment results of
AGC. However, the actual extent of D2 lymphadenectomy varies among surgeons because of a lacking consensus
on the anatomical definition of each lymph node station. This study is aimed to develop a consensus for D2
lymphadenectomy and also to qualify surgeons that can perform both laparoscopic and open D2 gastrectomy.
Methods/Design: This (KLASS-02-QC) is a prospective, observational, multicenter study to qualify the surgeons that
will participate in the KLASS-02-RCT, which is a prospective, randomized, clinical trial comparing laparoscopic and
open gastrectomy for AGC. Surgeons and reviewers participating in the study will be required to complete a
questionnaire detailing their professional experience and specific gastrectomy surgical background/training, and the
gastrectomy metrics of their primary hospitals. All surgeons must submit three laparoscopic and three open D2
gastrectomy videos, respectively. Each video will be allocated to five peer reviewers; thus each surgeon’s operations
will be assessed by a total of 30 reviews. Based on blinded assessment of unedited videos by experts’ review, a
separate review evaluation committee will decide whether or not the evaluated surgeon will participate in the
KLASS-02-RCT. The primary outcome measure is each surgeon’s proficiency, as assessed by the reviewers based on
evaluation criteria for completeness of D2 lymphadenectomy.
Discussion: We believe that our study for standardization of D2 lymphadenectomy and surgical quality control
(KLASS-02-QC) will guarantee successful implementation of the subsequent KLASS-02-RCT study. After making consensus
on D2 lymphadenectomy, we developed evaluation criteria for completeness of D2 lymphadenectomy. We also
developed a unique surgical standardization and quality control system that consists of recording unedited surgical
videos, and expert review according to evaluation criteria for completeness of D2 lymphadenectomy. We hope our
systematic approach will set a milestone in surgical standardization that is essential for surgical clinical trials.
Additionally, our methods will serve as a novel system for educating surgeons and assessing surgical proficiency.
Trial registration: NCT01283893.
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Laparoscopic gastrectomy is gaining wide acceptance for
treating early gastric cancer because of its favorable
short-term outcomes compared to open gastrectomy, in-
cluding reduced blood loss, less pain, and faster recovery
[1,2]. In addition, long-term outcomes following laparo-
scopic gastrectomy are comparable to conventional open
gastrectomy for early gastric cancer [3,4]. Consequently,
laparoscopic gastrectomy is now also considered for
treating advanced gastric cancer, to provide the potential
benefits of a minimally invasive surgical solution to this
disease [5,6].
For surgical treatment of advanced gastric cancer, gas-
trectomy with D2 lymphadenectomy is recommended as
a standard procedure in major guidelines because D2
lymphadenectomy results in better patient survival than
D1 lymphadenectomy [7-11]. Thus, for studies that
evaluate the surgical treatment results of advanced gastric
cancer, complete D2 lymphadenectomy is a mandatory
procedure. However, D2 dissection is known to be a tech-
nically challenging surgical procedure and dissection qual-
ity and completeness varies among surgeons. The actual
extent of D2 lymphadenectomy varies among surgeons be-
cause there remains a lack of consensus on the anatomical
definition of appropriate lymph node dissection extent
reflected in ambiguous definitions with the published
documentation [12]. Despite great efforts to enhance qual-
ity control in a previous study that compared D1 versus
D2 lymph node dissection, inadequate removal of lymph
node station(s) for complete D2 lymphadenectomy, i.e.,
the non-compliance rate, was reported to be 81.0% [13].
Considering the high rate of inadequate D2 lymphadenec-
tomy in open surgery, even worse results would be antici-
pated in laparoscopic surgery because of its increased
technical difficulty. To get accurate results in clinical trials
of laparoscopic and open D2 lymphadenectomy for ad-
vanced gastric cancer, only surgeons who can perform
exact D2 lymphadenectomy should participate, to ensure
objective comparisons.
As far as we know, there has been no system to object-
ively evaluate the gastrectomy procedure focused on D2
lymphadenectomy quality. Furthermore, no study has
yet attempted to standardize D2 lymphadenectomy dur-
ing laparoscopic or open gastrectomy for clinical trials.
Therefore, a tool that can assess the surgical proficiency
and quality of lymphadenectomy is necessary. Herein, we
report the development of a new surgical standardization
and quality control system for assessing D2 lymphadenec-
tomy. We intend to use this system to optimize our
planned randomized prospective clinical trial to compare
laparoscopic D2 lymphadenectomy with open D2 lymph-
adenectomy (KLASS-02-RCT, NCT01456598), to clarify
the surgical feasibility and oncological safety of laparo-
scopic gastrectomy for advanced gastric cancer. Beforeinitiating the prospective RCT, we conducted this quality
control study (KLASS-02-QC, NCT01283893) to make a
consensus for D2 lymphadenectomy and to qualify sur-




This quality control study (KLASS-02-QC) is a prospect-
ive, observational, multicenter study to assess surgeon
competency in performing laparoscopic and open D2
lymphadenectomy (Figure 1). Assessments are based on
expert rating of unedited surgical videos, according to
evaluation criteria for completeness of D2 lymphadenec-
tomy (Additional file 1: Table S1). Only qualified surgeons
will participate in the planned clinical trial comparing lap-
aroscopic and open gastrectomy for treating advanced
gastric cancer (KLASS-02-RCT). This study was reviewed




To qualify the surgeons participating in the clinical trial
(KLASS-02-RCT), which will compare laparoscopic ver-
sus open gastrectomy, with D2 lymphadenectomy.
Secondary aims
1) To determine the feasibility of surgical standardization
based on evaluation criteria for completeness of D2
lymphadenectomy; 2) To evaluate potential surgical profi-
ciency improvement due to the review process; and 3) To
assess potential relationships among the rated score,
surgeon professional background, and the perioperative




The role of the data center is to recruit participating sur-
geons and reviewers; to get signed non-disclosure agree-
ments and completed questionnaires of recruited surgeons
(Additional file 2: Table S2) and reviewers (Additional file 3:
Table S3); to support video recording services for open
gastrectomy cases; to blind the information regarding
the patients, surgeons, and reviewers; to distribute sub-
mitted surgical videos; to collect reviewer assessments
of surgical videos; and to disseminate committee deci-
sions on the surgeons that are selected for participation
in the subsequent RCT.
Reviewers
Korean and international surgeons will be invited as re-
viewers of surgical video recordings. To participate as a
Figure 1 Study schema.
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non-disclosure agreement and complete a reviewer ques-
tionnaire (Additional file 3: Table S3), which includes
information such as personal gastrectomy experience and
patient volume at their primary working hospital.
Review evaluation committee
The review evaluation committee consists of experts in
laparoscopic and open D2 lymphadenectomy, including
invited surgeon members of the Korean Gastric Cancer
Association and principal investigators of the KLASS-02-
RCT. Members of the committee developed a consensus
on the mandatory anatomical extent of lymph node dis-
section, evaluation criteria for completeness of D2 lymph-
adenectomy, and sample surgical videos were then
devoted based on this consensus. The review evaluation
committee is distinct from the reviewer group, and will be
the final determiner of a surgeon’s technical competency
and approval for participation in the KLASS-02-RCT,
based on the reviewers’ assessments and surgical videos
in a blinded way.
Study process
Evaluation criteria for completeness of D2
lymphadenectomy
Definition of D1 lymphadenectomy is removal of the
perigastric lymph nodes. Definition of D2 lymphadenec-
tomy is additional removal of a second tier of lymph
nodes in the extraperigastric areas, which generally fall
along branches of the celiac axis including the left gastric,
splenic, common hepatic, and proper hepatic arteries. Theassessment form consists of 22 elements of D2 lymph-
adenectomy that together evaluate the success or failure
to perform a surgical task (Additional file 1: Table S1).
Although the assessment form was made based on the
anatomical definition of lymph node stations, [12] pa-
rameters for assessing patient safety and surgical quality
are also included in the criteria.Sample videos of D2 lymphadenectomy
The review evaluation committee made unedited and
edited sample videos of laparoscopic and open gastrec-
tomy for surgeons, which satisfy the evaluation criteria for
completeness of D2 lymphadenectomy. The sample videos
clearly show the D2 lymphadenectomy, a total omentect-
omy with lymph node dissection of stations including 1, 3,
4, 5, 6, 7, 8a, 9, 11p and 12a, based on Japanese classifica-
tions are performed with appropriate annotations [12].Recruitment of reviewers and surgeons
Surgeon recruitment will be continued until 484 patients
have been enrolled in KLASS-02-RCT, at which point
planned analysis for safety related to morbidity and mor-
tality is planned.Reviewers Thirty reviewers are required to fully assess
the surgical videos of participating surgeons in this quality
control study. Thus, our target reviewer enrollment num-
ber is 50, which provide a sizeable margin to account for
potential drop-outs and work overload.
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open and laparoscopic gastrectomy in clinical practice.
After public offering of study participation to the members
of the Korean Gastric Cancer Association, candidates will
be accepted who satisfy following criteria: Surgeons who
have personally performed more than 50 cases of each
gastrectomy approach (i.e., laparoscopic and open), and
surgeons that work in institutions where more than 80
gastrectomies are performed annually. To participate, the
surgeon must obtain approval required by the Institutional
Review Board of each institute, and should submit a com-
pleted surgeon questionnaire (Additional file 2: Table S2).
This questionnaire includes surgeon information such as
personal gastrectomy experience, annual case volume at
their institute, and whether their institute has a specialized
multidisciplinary team for gastric cancer treatment.
Recording unedited surgical videos
Criteria of patients for video recording: Patients whose
operation will be recorded are required to provide
written informed consent. Patients with mental incom-
petency, are illiterate, pregnant, or are <20 years old or
>80 years old will not be asked to participate in this
study. Patients must have documented biopsy-proven
gastric cancer without distant lymph node metastasis
or plans for combined operations. While all resectable
gastric cancer patients without adjacent organ invasion
are candidates for an open gastrectomy procedure, pa-
tients who will undergo a laparoscopic surgery must have
gastric cancer without evidence of serosal invasion and
extra-perigatric lymph node metastasis, as determined by
evaluation of preoperative CT-scans, upper endoscopy, or
endoscopic ultrasound.
Video recording: Recommended surgical procedures
are same as those provided in the sample videos. Recon-
struction methods, surgical instruments for anastomosis,
and drainage insertion are in accordance with the sur-
geon’s preference. Video recording should clearly identify
the extent of lymph node dissection and should record the
entire procedure, without edition. No identifiable informa-
tion of the patient or surgeon should be recorded.
Video submissions and assessment
Unedited videos of three laparoscopic and three open
gastrectomies must be submitted by each participating
surgeon to the data center. At the same time, case re-
port forms (CRFs) containing perioperative surgical out-
comes also will be submitted. The data center will blind
the surgeon information and five reviewers will be ran-
domly allocated to evaluate each video. Reviewers will
assess each video based on the evaluation criteria for
completeness of D2 lymphadenectomy, and will also
give general impression and comments regarding sur-
geon performance.Decision-making on surgeon qualification
The review evaluation committee will make a decision
on surgeon qualification to participate in the KLASS-02-
RCT based on the reviewers’ assessments. Additional
review of surgical video could be necessary for selected
cases. All CRFs containing perioperative surgical out-
come will be blinded to preclude potential reviewer and
committee bias. Evaluation committee decisions will be
categorized as: (1) Qualified; the surgeon’s operation
proficiency is sufficient to accept them as qualified to
participate in the KLASS-02-RCT; (2) Resubmission
Required; when the surgeon performance in the sub-
mitted operation videos of either or both gastrectomy
methods are not satisfactory, the evaluation committee
will ask for resubmission of a video and CRF for the
failed approach(es); and (3) Not-Qualified; surgeons
whose operation performance is insufficient, and must
be evaluated by submitting another six videos after get-
ting re-approval from their Institutional Review Board.
If a surgeon fails to be deemed qualified even after
video resubmission, that surgeon will be regarded as
Not-Qualified and will not participate in the RCT.
Timeline
All prospective RCT surgeons must participate in this
quality control trial and only qualified surgeons will par-
ticipate in the subsequent RCT. All surgeons must submit
all required surgical videos and CRFs containing peri-
operative surgical outcome within 6 months after IRB
approval. Otherwise, the surgeon will be regarded as a
study dropout. The reviewer assessment process will be
completed within 1 month after submission of required
videos and CRFs. The review evaluation committee will
make decisions after completing the review process for
every five sequentially evaluated surgeons.
Statistical considerations: estimated number of surgeons,
video recordings, reviewers, and assessments
This study is not a hypothesis-testing trial and therefore
does not include an accepted approach for power calcu-
lation. Lacking previous reports on the criteria for surgical
competency, we estimated the number of surgical videos
and reviewers that are sufficient to assess surgeon profi-
ciency, within realistic ranges. An overall target of six
videos for each surgeon and five independent reviewers
for each video were set. Considering patient variation,
three operations for each surgical approach would be an
acceptable number for surgeon assessment. Considering
the number of expert surgeons at hospitals with appro-
priate volume, the estimated number of participating
surgeons in Korea is approximately 50. Each surgeon
must submit the minimum of six videos (three for each
procedure), and up to eight videos if required for re-
evaluation. The estimated total number of videos will
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tient enrollment for gastrectomy video recording will
number 350.
Analysis plan
To explore qualified surgeon characteristics, descriptive
statistical methods without formal testing will be used.
For evaluating the secondary measurements, data will be
analyzed using both quantitative and qualitative tech-
niques. For assessing inter-reviewer agreement on video
ratings, a generalized Kappa statistic will be determined.
The major factor of the qualification decision, i.e., the
average reviewer score based on predetermined criteria
for submitted operation videos, will be used for the
quantitative evaluation of the secondary measurements.
Relationships among the surgeon proficiency rating scores,
background information of the participating surgeons and
reviewers, decision results by the review evaluation
committee, and perioperative surgical outcomes will be
analyzed. Data will be analyzed using SAS 9.2 software
(SAS Institute Inc., Cary, NC, USA). For all statistical
purposes, p < 0.05 will be considered indicative of statis-
tically significant differences.
Discussion
We believe that effectiveness and safety of D2 dissection
in advanced gastric cancer can be evaluated only when
the D2 surgical procedure is standardized and surgical
quality is controlled. If the surgery as an intervention in
a clinical trial is of variable quality, the results will not
be helpful to identify accurate differences in surgical out-
comes using different specific treatments. Such variability
would undermine the study findings. Despite attempting
quality control of lymph node dissection, the results of a
previous study comparing D1 versus D2 lymphadenec-
tomy were weakened because of surgeon non-compliance
(inadequate removal of lymph node stations) and contam-
ination (lymph nodes were detected outside the intended
level of dissection) rates of 81.0% and 27.1%, respectively
[13]. Furthermore, the morbidity and mortality of the D2
group were 43% and 10%, respectively [14]. To compare
the surgical outcome of laparoscopic and open D2 lymph-
adenectomy, lymph node dissection should be a homo-
genous surgical intervention. We designed this study
protocol to assess the proficiency of a surgeon who per-
forms both laparoscopic and open D2 lymphadenectomy.
To assure that the standardized procedure is performed, we
developed a standardization and quality control protocol.
For an RCT comparing two surgical approaches for
lymphadenectomy suffers from either high inter-surgeon
or intra-surgeon performance variability, this will ad-
versely affect the power to identify significant differ-
ences in outcomes between the two treatments. Thus,
we prepared sample videos for surgeons to demonstrateessential principles of lymphadenectomy that must be
maintained during surgery. Sample videos with annota-
tions were made for easier understanding of the ana-
tomical dissection of each lymph node station. Video
demonstration is markedly superior to merely reading
the written definitions of the appropriate anatomical ex-
tent of lymph node station excision during gastrectomy.
We believe that distributing these sample videos will
help to implement the consensus by the review evalu-
ation committee on the mandatory anatomical extent of
lymph node dissection required, and performed by sur-
geons participating in the study.
To control surgical quality, we suggest assessment
using unedited surgical video as assessment and learning
tools. Unedited videos can clearly show not only the
lymphadenectomy extent but also adverse events that
may happen during surgery, such as injuries to adjacent
organs and accidental bleeding. Any event that can
jeopardize patient safety would be identified by review-
ing unedited videos. In addition, using video clips can
help peer reviewers to assess the proficiency of a sur-
geon without personally visiting the operating theater.
Removing this limitation will increase the efficiency of
the review process because we can provide more robust
assessment of surgical proficiency by recruiting a larger
number of reviewers.
To objectively assess the surgeon’s proficiency, we pre-
pared an assessment form consisting of 22 evaluation
criteria for completeness of D2 lymphadenectomy. By
analyzing inter-reviewer agreement based on the back-
ground information of the reviewer, we expect to de-
termine the required number of surgical videos and
reviewers required for optimal assessment. Further-
more, our system provides feedback to each surgeon in
the form of proficiency assessment score and allow for
surgeon learning and improvement if they fail to ini-
tially qualify, by requesting resubmission of additional
unedited videos. We will be able to evaluate whether
the resubmission process improves the surgical profi-
ciency of a surgeon. If this is the case, our method of
standardization and quality control can be used for
educating novice surgeons, as well as experienced sur-
geons that are learning new surgical techniques.
Developing a quality control consensus for D2 lymph-
adenectomy performance during gastrectomy, recording
unedited surgical videos, and assessing surgeon profi-
ciency according to evaluation criteria for completeness
of D2 lymphadenectomy may provide important bene-
fits to clinical practice. Laparoscopic D2 lymphadenec-
tomy for advanced gastric cancer itself was criticized for
its applicability because of its inherent technical difficulty.
If laparoscopic D2 lymphadenectomy benefits patients, it
should not be discarded because of technical difficulty; in-
stead, solutions should be sought to improve technique
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implementing a system for surgical standardization and
quality control during gastrectomy. This method will pro-
vide important new information and education to improve
patient surgical outcomes when treating gastric cancer
with minimally invasive laparoscopic approaches.
In conclusion, we believe that our study for stan-
dardization of D2 lymphadenectomy and surgical quality
control (KLASS-02-QC) will guarantee successful imple-
mentation of the subsequent clinical trial comparing lap-
aroscopic and open D2 lymphadenectomy for advanced
gastric cancer (KLASS-02-RCT). After making consensus
on D2 lymphadenectomy, we developed evaluation criteria
for completeness of D2 lymphadenectomy. We also devel-
oped a unique surgical standardization and quality control
system that consists of recording unedited surgical videos,
and expert review according to evaluation criteria for
completeness of D2 lymphadenectomy. We hope that
our systematic approach will set a milestone in surgical
standardization that is essential for surgical clinical tri-
als. Additionally, our methods will serve as a novel sys-
tem for educating surgeons and for assessing surgical
proficiency.
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